A. Jaźwa

发表

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

M. Giacca, S. Ylä-Herttuala, H. Karvinen, 2011, Gene Therapy.

Limb ischemia and vessel regeneration: Is there a role for VEGF?

A. Józkowicz, A. Grochot-Przęczek, Urszula Florczyk, 2016, Vascular pharmacology.

Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia

L. Zentilin, M. Giacca, A. Józkowicz, 2013, Vascular cell.

Angiogenic transcriptome of human microvascular endothelial cells: Effect of hypoxia, modulation by atorvastatin.

G. Molema, A. Józkowicz, J. Dulak, 2006, Vascular pharmacology.

Differential Inflammatory MicroRNA and Cytokine Expression in Pulmonary Sarcoidosis

K. Sladek, A. Józkowicz, J. Dulak, 2014, Archivum Immunologiae et Therapiae Experimentalis.

Effects of plant extracts on angiogenic activities of endothelial cells and keratinocytes.

M. Heinrich, J. Cisowski, J. Dulak, 2005, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Heme oxygenase-1-dependent and -independent regulation of angiogenic genes expression: effect of cobalt protoporphyrin and cobalt chloride on VEGF and IL-8 synthesis in human microvascular endothelial cells.

B. Wegiel, A. Józkowicz, J. Dulak, 2005, Cellular and molecular biology.

New vectors and strategies for cardiovascular gene therapy.

A. Józkowicz, J. Dulak, A. Jaźwa, 2007, Current gene therapy.

Splenic Ly 6 C ( hi ) monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice

A. Józkowicz, J. Dulak, M. Meloni, 2017 .

Splenic Ly6Chi monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deficient mice

A. Józkowicz, J. Dulak, M. Meloni, 2017, Basic Research in Cardiology.

Splenic Ly6C hi monocytes contribute to adverse late post-ischemic left ventricular remodeling in heme oxygenase-1 deﬁcient mice

A. Józkowicz, J. Dulak, M. Meloni, 2017 .

Atorvastatin prevents hypoxia-induced inhibition of endothelial nitric oxide synthase expression but does not affect heme oxygenase-1 in human microvascular endothelial cells.

G. Molema, J. Dorosz, A. Józkowicz, 2006, Atherosclerosis.

Atorvastatin affects several angiogenic mediators in human endothelial cells.

W. Dichtl, A. Józkowicz, J. Dulak, 2005, Endothelium : journal of endothelial cell research.

Heme oxygenase-1 is required for angiogenic function of bone marrow-derived progenitor cells: role in therapeutic revascularization.

O. Volger, A. Józkowicz, A. Grochot-Przęczek, 2014, Antioxidants & redox signaling.

Nrf2 regulates angiogenesis: effect on endothelial cells, bone marrow-derived proangiogenic cells and hind limb ischemia.

M. Maleszewska, A. Józkowicz, A. Grochot-Przęczek, 2014, Antioxidants & redox signaling.

Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice

A. Józkowicz, J. Dulak, C. Emanueli, 2012, Cardiovascular research.

Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice

T. Ochiya, P. Kucharzewska, A. Józkowicz, 2010, Genetic vaccines and therapy.

HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells.

L. Poellinger, J. Węgrzyn, A. Józkowicz, 2009, Antioxidants & redox signaling.

HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses - Effects modified by concomitant VEGF overexpression.

C. Pichon, A. Józkowicz, J. Dulak, 2015, Vascular pharmacology.

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

M. Giacca, S. Ylä-Herttuala, H. Karvinen, 2011, Gene Therapy.

Comment on “A Novel Role of Hypoxia-Inducible Factor in Cobalt Chloride- and Hypoxia-Mediated Expression of IL-8 Chemokine in Human Endothelial Cells”1

A. Józkowicz, J. Dulak, A. Loboda, 2007, The Journal of Immunology.

Targeting heme oxygenase-1 for neuroprotection and neuroinflammation in neurodegenerative diseases.

A. Cuadrado, A. Jaźwa, 2010, Current drug targets.

DISAPPEARANCE OF PENDIMETHALIN IN SOIL AND ITS RESIDUE IN RIPE FENNEL

A. Jaźwa, E. Szpyrka, S. Sadło, 2009 .

Heme oxygenase-1 inhibits myoblast differentiation by targeting myomirs.

M. Cieśla, A. Józkowicz, A. Grochot-Przęczek, 2012, Antioxidants & redox signaling.

Gene therapy on demand: site specific regulation of gene therapy.

A. Józkowicz, Urszula Florczyk, J. Dulak, 2013, Gene.

Heme oxygenase-1 and the vascular bed: from molecular mechanisms to therapeutic opportunities.

J. Cisowski, A. Agarwal, A. Józkowicz, 2008, Antioxidants & redox signaling.

Letter by Loboda et al Regarding Article, "Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis": IL-8 Is Not Present in Murine Genome Hence it Cannot Be Responsible for the Bach1 Effect on Angiogenesis in Mice.

A. Józkowicz, A. Grochot-Przęczek, Urszula Florczyk, 2015, Circulation research.

Pharmacological targeting of the transcription factor Nrf2 at the basal ganglia provides disease modifying therapy for experimental parkinsonism.

A. I. Rojo, A. Cuadrado, J. Fernández-Ruiz, 2011, Antioxidants & redox signaling.

Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes.

J. Drukała, J. Cisowski, A. Józkowicz, 2006, Free radical biology & medicine.

Therapeutic potential of heme oxygenase-1 in cardiovascular disease

A. Józkowicz, Urszula Florczyk, J. Dulak, 2011 .

Involvement of microRNAs in the inflammatory pathways of pulmonary sarcoidosis.

K. Sladek, N. Kachamakova-Trojanowska, A. Józkowicz, 2015, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

Critical View on Mesenchymal Stromal Cells in Regenerative Medicine.

A. Józkowicz, J. Dulak, W. Nowak, 2017, Antioxidants & redox signaling.

The new model of mRNA degradation based on the recent advances in the DcpS enzyme specificity towards m 7 GDP

M. Kimmel, T. Lipniacki, A. Brasier, 2014 .

Different Susceptibility to the Parkinson's Toxin MPTP in Mice Lacking the Redox Master Regulator Nrf2 or Its Target Gene Heme Oxygenase-1

A. I. Rojo, A. Cuadrado, J. Fernández-Ruiz, 2010, PloS one.

Complex effect of atorvastatin on angiogenic gene expression in normoxic and hypoxic microvascular endothelial cells

G. Molema, A. Józkowicz, J. Dulak, 2005 .

Differential Inflammatory MicroRNA and Cytokine Expression in Pulmonary Sarcoidosis

A. Józkowicz, J. Dulak, L. Kasper, 2014, Archivum Immunologiae et Therapiae Experimentalis.

L 1 . 3 Mutations of the catalytic subunit of class 1 A PI-3 K are constitutively active in hematopoietic cells in vitro and in vivo

J. McCubrey, L. Trümper, A. Martelli, 2008 .

Therapeutic potential of heme oxygenase-1 in cardiovascular disease

A. Józkowicz, J. Dulak, A. Jaźwa, 2011 .

HIF-1 induction attenuates Nrf2-dependent IL-8 expression in human endothelial cells.

L. Poellinger, J. Węgrzyn, A. Józkowicz, 2009, Antioxidants & redox signaling.

HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses - Effects modified by concomitant VEGF overexpression.

C. Pichon, A. Józkowicz, J. Dulak, 2015, Vascular pharmacology.